GlassScriptPhysician profile
Robert J Nelson
NPI 1003110172
$13,284.61
in general payments reported to CMS, 2019-2025
15 companies · $301 in 2025
The $301 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,312 · 2022: $144 · 2023: $232 · 2024: $11K · 2025: $301.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $3,870 · Consulting Fee: $3,136 · Travel and Lodging: $3,074 · Food and Beverage: $1,749.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $3,870.00 |
| Consulting Fee | $3,136.00 |
| Travel and Lodging | $3,073.94 |
| Food and Beverage | $1,748.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $11,144.67 | 2021-2025 | |
| Medtronic, INC. | $1,516.10 | 2021-2024 | Minimed 780g |
| Lilly USA, LLC | $145.38 | 2022-2025 | Mounjaro, Zepbound, Amyvid |
| Beta Bionics, INC. | $133.61 | 2024 | Ilet Bionic Pancreas |
| Abbvie INC. | $73.50 | 2021-2023 | |
| Pfizer INC. | $58.95 | 2021-2025 | |
| Amgen INC. | $42.89 | 2025 | Evenity, Prolia |
| Biohaven Pharmaceutical Holding Company LTD. | $30.16 | 2022 | |
| Nestle Healthcare Nutrition INC. | $26.92 | 2021 | |
| Astellas Pharma US INC | $23.72 | 2025 | Veozah |
| Merck Sharp & Dohme LLC | $20.91 | 2022 | |
| Otsuka America Pharmaceutical, INC. | $19.22 | 2024 | Rexulti |
| Novartis Pharmaceuticals Corporation | $18.62 | 2025 | |
| Novo Nordisk INC | $15.77 | 2023 | Rybelsus |
| Exact Sciences Corporation | $14.19 | 2025 | Cologuard Collection Kit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Nelson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.